The Europe Tele-epilepsy Market is expected to witness market growth of 15.2% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Tele-epilepsy Market by Country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $85.9 million by 2031. The UK market is exhibiting a CAGR of 14.2% during 2024-2031. Additionally, the France market would experience a CAGR of 16.1% during 2024-2031.
At the heart of tele-epilepsy is the capacity to connect patients with epilepsy specialists through secure, high-definition video consultations, real-time data sharing, and advanced digital health tools. These devices enable healthcare clinicians to monitor seizure activity, adjust medications, and deliver prompt interventions without necessitating patients to travel long distances or wait for appointments.
For patients who are vulnerable to frequent, unpredictable seizures, this remote access is a significant improvement over traditional care, as it offers a level of flexibility and responsiveness that was previously unavailable. Tele-epilepsy also promotes a sense of continuity in care, as patients can maintain consistent communication with their providers and adhere to follow-up schedules that are frequently challenging to accomplish through in-person visits alone.
France has seen increased demand for tele-epilepsy, largely fueled by its government’s efforts to reduce healthcare disparities in rural and underserved areas. The French Ministry of Health has actively supported telemedicine through the “Ma Santé 2022” plan, which aims to provide remote care options for patients in areas with limited access to specialists.
As part of this initiative, the government has funded healthcare providers to establish tele-epilepsy services, ensuring that epilepsy patients can access specialized care regardless of their location. The French health insurance system also covers telemedicine consultations, supporting patient adoption. France’s emphasis on reducing regional healthcare gaps and improving accessibility has positioned tele-epilepsy as essential for nationwide neurological care. Hence, the regional market will experience expedited growth in the coming years.
The Germany market dominated the Europe Tele-epilepsy Market by Country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $85.9 million by 2031. The UK market is exhibiting a CAGR of 14.2% during 2024-2031. Additionally, the France market would experience a CAGR of 16.1% during 2024-2031.
At the heart of tele-epilepsy is the capacity to connect patients with epilepsy specialists through secure, high-definition video consultations, real-time data sharing, and advanced digital health tools. These devices enable healthcare clinicians to monitor seizure activity, adjust medications, and deliver prompt interventions without necessitating patients to travel long distances or wait for appointments.
For patients who are vulnerable to frequent, unpredictable seizures, this remote access is a significant improvement over traditional care, as it offers a level of flexibility and responsiveness that was previously unavailable. Tele-epilepsy also promotes a sense of continuity in care, as patients can maintain consistent communication with their providers and adhere to follow-up schedules that are frequently challenging to accomplish through in-person visits alone.
France has seen increased demand for tele-epilepsy, largely fueled by its government’s efforts to reduce healthcare disparities in rural and underserved areas. The French Ministry of Health has actively supported telemedicine through the “Ma Santé 2022” plan, which aims to provide remote care options for patients in areas with limited access to specialists.
As part of this initiative, the government has funded healthcare providers to establish tele-epilepsy services, ensuring that epilepsy patients can access specialized care regardless of their location. The French health insurance system also covers telemedicine consultations, supporting patient adoption. France’s emphasis on reducing regional healthcare gaps and improving accessibility has positioned tele-epilepsy as essential for nationwide neurological care. Hence, the regional market will experience expedited growth in the coming years.
List of Key Companies Profiled
- Shimmer Research Ltd.
- Emotiv Inc.
- CortiCare, Inc.
- SEVARO
- Tele Specialists
- Real Time Tele-Epilepsy Consultants
- ScienceSoft USA Corporation
- Zeto, Inc.
- TeleEEG
- Epitel, Inc.
Market Report Segmentation
By Patient
- Adult
- Pediatric
By End Use
- Healthcare Consumers
- Hospitals Providers
- Payers
By Component
- Software
- Hardware
- Services
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Tele-epilepsy Market by Patient
Chapter 5. Europe Tele-epilepsy Market by End Use
Chapter 6. Europe Tele-epilepsy Market by Component
Chapter 7. Europe Tele-epilepsy Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Shimmer Research Ltd.
- Emotiv Inc.
- CortiCare, Inc.
- SEVARO
- Tele Specialists
- Real Time Tele-Epilepsy Consultants
- ScienceSoft USA Corporation
- Zeto, Inc.
- TeleEEG
- Epitel, Inc.
Methodology
LOADING...
